Association between liver histology, carotid ultrasonography and retinal vascular changes in patients with nonalcoholic fatty liver disease (NAFLD)

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 3, 2012, Pages 609-614

  Bǎloşeanu, Cristina L ^a   Streba, Costin Teodor ^a   Vere, C C ^a   Comǎnescu, Violeta ^b   Rogoveanu, I ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

^b EMERGENCY COUNTY HOSPITAL   (Romania)

Author keywords

Intima media thickness; Nonalcoholic fatty liver disease; Pulsatility index; Resistivity index; Retinal vascular disorders

Indexed keywords

EID: 84867033274     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 2003, 37(4):917-923.
2. Angulo P. Nonalcoholic fatty liver disease, N Engl J Med, 2002, 346(16):1221-1231.
3. Angelico F, Del Ben M, Conti R, Francioso S, Feole K, Maccioni D, Antonini TM, Alessandri C. Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases, J Gastroenterol Hepatol, 2003, 18(5):588-594.
4. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol, 2003, 15(5):539-543.
5. Targher G, Bertolini L, Padovani R, Zenari L, Zoppini G, Falezza G. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation, Diabetes Care, 2004, 27(10):2498-2500.
6. Brea A, Mosquera D, Martín E, Arizti A, Cordero JL, Ros E. Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study, Arterioscler Thromb Vasc Biol, 2005, 25(5):1045-1050.
7. Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J, Schminke U, Kessler C, John U. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis, World J Gastronterol, 2005, 11(12):1848-1853.
8. O'Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction, Am J Cardiol, 2002, 90(10C):18L-21L.
9. Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G. Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease, Arterioscler Thromb Vasc Biol, 2005, 25(12): 2687-2688.
10. Fukuhara T, Hida K. Pulsatility index at the cervical internal carotid artery as a parameter of microangiopathy in patients with type 2 diabetes, J Ultrasound Med, 2006, 25(5):599-605.
11. Staub D, Meyerhans A, Bundi B, Schmid HP, Frauchiger B. Prediction of cardiovascular morbidity and mortality: comparison of the internal carotid artery resistive index with the common carotid artery intima-media thickness, Stroke, 2006, 37(3):800-805.
12. Hayreh SS, Podhajsky PA, Zimmerman MB. Retinal artery occlusion: associated systemic and ophthalmic abnormalities, Ophthalmology, 2009, 116(10):1928-1936.
13. Cǎlugǎru D. Risk factors in central retinal vein occlusion, Oftalmologia, 2011, 55(2):27-37.
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III), JAMA, 2001, 285(19):2486-2497.
15. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity, Gastroenterology, 1999, 116(6):1413-1419.
16. rd edition, Mosby, 2008.
17. Streba LAM, Cârstea D, Mitruţ P, Vere CC, Dragomir N, Streba CT. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review, Rom J Morphol Embryol, 2008, 49(1):13-20.
18. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference, Hepatology, 2003, 37(5):1202-1219.
19. Adams LA, Angulo P. Recent concepts in non-alcoholic fatty liver disease, Diabet Med, 2005, 22(9):1129-1133.
20. Farrell GC, Chitturi S, Lau GK, Sollano JD; Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary, J Gastroenterol Hepatol, 2007, 22(6):775-777.
21. Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G, Valenti L, Maraschi A, Catapano A, Fargion S. Carotid artery intima-media thickness in nonalcoholic fatty liver disease, Am J Med, 2008, 121(1):72-78.
22. Streba CT, Nita-Stefanescu L, Streba LAM, Pirici D, Sandulescu L, Vere CC, Rogoveanu I, Mogoanta L, Comanescu M. Duration of a fructose rich diet influences the severity of liver injury and metabolic changes in an animal rat model, Gut/Enteroscopy, 2011, 60(Suppl II):A134.
23. Vere CC, Neagoe D, Streba CT, Prejbeanu I, Ianosi G, Comanescu V, Pirici D. Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology. Rom J Morphol Embryol 2010; 51(3): 509-514.
24. Egyed-Zsigmond I, Jung I, Egyed-Zsigmond I, Marton G, Gurzu S, Mezei T. Immunohistochemical comparative study of fibrosis and biliary ductular reaction in alcoholic and viral chronic hepatitis, Rom J Morphol Embryol, 2010, 51(2):265-269.
25. Targher G, Bertolini L, Padovani R, Poli F, Scala L, Zenari L, Zoppini G, Falezza G. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients, J Endocrinol Invest, 2006, 29(1): 55-60.
26. Sookoian S, Pirola CJ. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review, J Hepatol, 2008, 49(4):600-607.
27. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study, Am J Epidemiol, 1991, 134(3):250-256.
28. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF), Hepatology, 2000, 32(3):477-481.
29. Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy, Can J Gastroenterol, 2000, 14(6):543-548.
30. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, Grimaldi A, Capron F, Poynard T; LIDO Study Group. Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 2005, 128(7):1898-1906.
31. Hübscher SG. Role of liver biopsy in the assessment of nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, 2004, 16(11):1107-1115.
32. Das S, Chakrabarty K, Patnaik M, Roul L, Mohanty J, Chandra Singh S. The relationship of carotid plaque, intima media thickness (IMT), resistivity index (RI) and pulsatility index (PI) in Asian-Indian patients with acute ischemic stroke with and without type2 DM, International Journal of Clinical Medicine, 2011, 2(5):561-567.
33. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E; Mexico City diabetes study. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City Diabetes Study, Diabetes Care, 2005, 28(7):1757-1762.
34. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM. Liver markers and development of the metabolic syndrome: the Insulin Resistance Atherosclerosis Study, Diabetes, 2005, 54:3140-3147.
35. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome, Arterioscler Thromb Vasc Biol, 2004, 24(1):29-33.
36. Targher G, Bertolini L, Zenari L. Hypoadiponectinemia is closely associated with nonalcoholic hepatic steatosis in obese subjects, Diabetes Care, 2004, 27(8):2085-2086.
37. Charlton M, Sreekumar R, Rasmussen D, Lindor K, Nair KS. Apolipoprotein synthesis in nonalcoholic steatohepatitis, Hepatology, 2002, 35(4):898-904.
38. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome, Lancet, 2005, 365(9468):1415-1428.
39. Recchia FM, Brown GC. Systemic disorders associated with retinal vascular occlusion, Curr Opin Ophthalmol, 2000, 11(6):462-467.
40. Wong TY, Islam FM, Klein R, Klein BE, Cotch MF, Castro C, Sharrett AR, Shahar E. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA), Invest Ophthalmol Vis Sci, 2006, 47(6):2341-2350.
41. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A metaanalysis of thrombophilic factors, Thromb Haemost, 2005, 93(6):1021-1026.
42. Stojakovic T, Scharnagl H, März W, Winkelmann BR, Boehm BO, Schmut O. Low density lipoprotein triglycerides and lipoprotein(a) are risk factors for retinal vascular occlusion, Clin Chim Acta, 2007, 382(1-2):77-81.